Results 61 to 70 of about 34,245 (290)
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Shrinkage methods for estimating the parameters of a regression model with autoregressive integrated moving average (ARIMA) errors are presented when some of the regression parameters are restricted to a subspace.
Sharandeep Pandher +2 more
doaj +1 more source
Optimal method in multiple regression with structural changes
In this paper, we consider an estimation problem of the regression coefficients in multiple regression models with several unknown change-points. Under some realistic assumptions, we propose a class of estimators which includes as a special cases ...
Chen, Fuqi, Nkurunziza, Sévérien
core +1 more source
Combining Minimax Shrinkage Estimators [PDF]
Abstract When one estimates a multivariate normal mean, the use of Stein estimation entails both the grouping of coordinates and the selection of a set of targets toward which to shrink each group. In this article we propose new minimax multiple shrinkage estimators that allow for multiple specifications of these aspects.
openaire +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Following the idea presented with regard to the elastic-net and Liu-LASSO estimators, we proposed a new penalized estimator based on the Kibria–Lukman estimator with L1-norms to perform both regularization and variable selection.
Adewale Folaranmi Lukman +5 more
doaj +1 more source
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley +1 more source
Introduction In classical methods of statistics, the parameter of interest is estimated based on a random sample using natural estimators such as maximum likelihood or unbiased estimators (sample information).
azadeh kiapour
doaj
Probability Distribution of Random Ridge Factor [PDF]
In this paper, we concerned with the research about the probability distribution of random ridge factor. The estimator of regression parameter is characterized as the shrunken estimator.
doaj +1 more source

